Evidence map›Paper›PMID 17895966›Full record

ArticlePloS one2007

Identification of upper respiratory tract pathogens using electrochemical detection on an oligonucleotide microarray.

Michael J Lodes, Dominic Suciu, Jodi L Wilmoth, Marty Ross, Sandra Munro, Kim Dix, Karen Bernards, Axel G Stöver, Miguel Quintana, Naomi Iihoshi and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Direct multiplexed whole genome sequencing of respiratory tract samples reveals full viral genomic information.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2015
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Development of adenoviral vector-based mucosal vaccine against influenza.Journal of molecular medicine (Berlin, Germany) · 2011
    Review
  16. Article
  17. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2010
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michael J LodesCombiMatrix Corporation, Mukilteo, Washington, USA. mlodes@combimatrix.com
Dominic Suciu
Jodi L Wilmoth
Marty Ross
Sandra Munro
Kim Dix
Karen Bernards
Axel G Stöver
Miguel Quintana
Naomi Iihoshi
Wanda J Lyon
David L Danley
Andrew McShea
CombiMatrix · USU.S. Army Center for Health Promotion and Preventive Medicine · USWright-Patterson Air Force Base · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial and viral upper respiratory infections (URI) produce highly variable clinical symptoms that cannot be used to identify the etiologic agent. Proper treatment, however, depends on correct identification of the pathogen involved as antibiotics provide little or no benefit with viral infections. Here we describe a rapid and sensitive genotyping assay and microarray for URI identification using standard amplification and hybridization techniques, with electrochemical detection (ECD) on a semiconductor-based oligonucleotide microarray. The assay was developed to detect four bacterial pathogens (Bordetella pertussis, Streptococcus pyogenes, Chlamydia pneumoniae and Mycoplasma pneumoniae) and 9 viral pathogens (adenovirus 4, coronavirus OC43, 229E and HK, influenza A and B, parainfluenza types 1, 2, and 3 and respiratory syncytial virus. This new platform forms the basis for a fully automated diagnostics system that is very flexible and can be customized to suit different or additional pathogens. Multiple probes on a flexible platform allow one to test probes empirically and then select highly reactive probes for further iterative evaluation. Because ECD uses an enzymatic reaction to create electrical signals that can be read directly from the array, there is no need for image analysis or for expensive and delicate optical scanning equipment. We show assay sensitivity and specificity that are excellent for a multiplexed format.

Indexed as

AdenoviridaeBacterial InfectionsBordetella pertussisChlamydophila pneumoniaeCoronavirus 229E, HumanCoronavirus OC43, HumanDNA, BacterialDNA, ViralElectrochemistryHumansInfluenza A virusInfluenza B virusMycoplasma pneumoniaeOligonucleotide Array Sequence AnalysisParainfluenza Virus 1, HumanParainfluenza Virus 2, HumanDNA, BacterialDNA, Viral

Identifiers

PMID17895966
PMCPMC1976596
OpenAlexW2038306186

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.